This intimate, invitation-only event for media and health care investment analysts will be hosted by Cancer Research Institute at the New York Academy of Sciences. It will feature both a panel of leading academic scientific experts in immunotherapy, including 2018 Nobel Prize winner and Director of CRI’s Scientific Advisory Council, Dr. James P. Allison, and a fireside chat with chief science officers representing pharma and biotech leaders to share their points of view on what’s next in the IO field.
Friday, June 21, 2019
Panel Sessions: 10am-12pm
Lunch Reception: 12pm
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, Floor 40
New York, NY 10007
James P. Allison, Ph.D., 2018 Nobel Laureate
Chair, Department of Immunology, University of Texas MD Anderson Cancer Center
Philip D. Greenberg, M.D.
Head of Immunology, Fred Hutchinson Cancer Research Center
Robert H. Vonderheide, M.D., D.Phil.
Director, Abramson Cancer Center, University of Pennsylvania
Jill O'Donnell-Tormey, Ph.D. (Moderator)
CEO and Director of Scientific Affairs, Cancer Research Institute
Industry Fireside Chat
Awny Farajallah, M.D., FACP
Vice President, Head U.S. Medical, Bristol-Myers Squibb
George D. Yancopoulos, M.D., Ph.D.
Founder, President, and Chief Scientific Officer, Regeneron
Meg Tirrell (Moderator)
Reporter, Biotechnology and Pharmaceuticals, CNBC
Andrew K. Tsai
Co-Chairman, CRI Board of Trustees
Co-Founder and Chief Investment Officer, Chalkstream Capital Group